A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18413723.
- Also identified by DOI 10.1158/0008-5472.CAN-07-6405 and PMC identifier 2828041.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Promoter hypermethylation is a prevalent phenomenon, found in virtually all cancer types studied thus far, and accounts for tumor suppressor gene silencing in the absence of genetic mutations. The mechanism behind the establishment and maintenance of such aberrant hypermethylation has been under intense study. Here, we have uncovered a link between aberrant gene silencing associated with promoter CpG island DNA methylation and the siRNA/miRNA processing enzyme, DICER, in human cancer cells. By comparing demethylated HCT116 colon cancer cells with HCT116 cells genetically rendered hypomorphic for DICER, we identified a group of epigenetically silenced genes that became reactivated in the absence of functional DICER. This reactivation is associated with a dramatic loss of localized promoter DNA hypermethylation. Thus, intact DICER is required to maintain full promoter DNA hypermethylation of select epigenetically silenced loci in human cancer cells.
Medical subject headings
- CpG Islands
- DNA Methylation
- Gene Silencing
- Promoter Regions, Genetic
- Ribonuclease III